Correlation Between Nasdaq and Celltrion Pharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nasdaq and Celltrion Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nasdaq and Celltrion Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nasdaq Inc and Celltrion Pharm, you can compare the effects of market volatilities on Nasdaq and Celltrion Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nasdaq with a short position of Celltrion Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nasdaq and Celltrion Pharm.

Diversification Opportunities for Nasdaq and Celltrion Pharm

-0.9
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Nasdaq and Celltrion is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding Nasdaq Inc and Celltrion Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celltrion Pharm and Nasdaq is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nasdaq Inc are associated (or correlated) with Celltrion Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celltrion Pharm has no effect on the direction of Nasdaq i.e., Nasdaq and Celltrion Pharm go up and down completely randomly.

Pair Corralation between Nasdaq and Celltrion Pharm

Given the investment horizon of 90 days Nasdaq Inc is expected to generate 0.34 times more return on investment than Celltrion Pharm. However, Nasdaq Inc is 2.93 times less risky than Celltrion Pharm. It trades about 0.14 of its potential returns per unit of risk. Celltrion Pharm is currently generating about -0.05 per unit of risk. If you would invest  7,235  in Nasdaq Inc on September 26, 2024 and sell it today you would earn a total of  657.00  from holding Nasdaq Inc or generate 9.08% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy98.41%
ValuesDaily Returns

Nasdaq Inc  vs.  Celltrion Pharm

 Performance 
       Timeline  
Nasdaq Inc 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Nasdaq Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Nasdaq may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Celltrion Pharm 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Celltrion Pharm has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Nasdaq and Celltrion Pharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nasdaq and Celltrion Pharm

The main advantage of trading using opposite Nasdaq and Celltrion Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nasdaq position performs unexpectedly, Celltrion Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celltrion Pharm will offset losses from the drop in Celltrion Pharm's long position.
The idea behind Nasdaq Inc and Celltrion Pharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios